The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTI Fluid Systems Regulatory News (TIFS)

Share Price Information for TI Fluid Systems (TIFS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 140.00
Bid: 139.60
Ask: 140.40
Change: -0.80 (-0.57%)
Spread: 0.80 (0.573%)
Open: 137.60
High: 142.80
Low: 137.60
Prev. Close: 140.80
TIFS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Stabilisation Notice

25 Oct 2017 07:00

RNS Number : 5272U
TI Fluid Systems PLC
25 October 2017
 

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

TI Fluid Systems plc

Stabilisation Notice

25 October 2017

Goldman Sachs International hereby gives notice that the entity undertaking stabilisation (the "Stabilising Manager" named below and its affiliates) may stabilise the offer of the following securities in accordance with Regulation (EU) No 596/2014 (Market Abuse Regulation) and Commission Delegated Regulation (EU) 2016/1052. Stabilisation transactions aim at supporting the market price of the Securities during the Stabilisation Period. Stabilisation may not necessarily occur and it may cease at any time.

The securities:

Issuer:

TI Fluid Systems plc (the "Company")

Securities:

Ordinary shares of the Company (ISIN: GB00BYQB9V88)

Offering size:

£406,678,019 excluding over-allotment option

Offer Price:

255 pence

Stabilisation:

Stabilising Manager (and central point within the meaning of Commission Delegated Regulation (EU) 2016/1052):

Goldman Sachs International, Peterborough Court, 133 Fleet Street, London EC4A 2BB

Contact: John Bentinck; telephone: +44 (0)20 7774 3408

Beginning of the Stabilisation Period:

25 October 2017

Stabilisation Period to end no later than:

23 November 2017

Trading venue where stabilisation may be undertaken:

London Stock Exchange, BATS, Chi-X

Over-allotment & Greenshoe Option:

Terms:

In connection with the Global Offer, the Stabilising Manager, or any of its agents, may (but will be under no obligation to), to the extent permitted by applicable law, over-allot Ordinary Shares or effect other stabilisation transactions with a view to supporting the market price of the Ordinary Shares at a level higher than that which might otherwise prevail in the open market. The Stabilising Manager is not required to enter into such transactions and such transactions may be effected on any securities market, over-the-counter market, stock exchange or otherwise and may be undertaken at any time during the period commencing on the date of the commencement of conditional dealings in the Ordinary Shares on the LSE and ending no later than 30 calendar days thereafter. There will be no obligation on the Stabilising Manager or any of its agents to effect stabilising transactions and there is no assurance that stabilising transactions will be undertaken. Such stabilisation, if commenced, may be discontinued at any time without prior notice. In no event will measures be taken to stabilise the market price of the Ordinary Shares above 255 pence per Offer Share. Except as required by law or regulation, neither the Stabilising Manager nor any of its agents intends to disclose the extent of any over-allotments made and/or stabilisation transactions conducted in relation to the Global Offer.

In connection with the Global Offer, the Stabilising Manager may, for stabilisation purposes, over-allot Ordinary Shares up to a maximum of 15% of the total number of Ordinary Shares comprised in the Global Offer.

The Over-allotment Option is exercisable in whole or in part, upon notice by the Stabilising Manager, at any time on or before the 30th calendar day after the commencement of conditional dealings in the Ordinary Shares on the LSE. Any Over-allotment Shares made available pursuant to the Over-allotment Option will rank pari passu in all respects with all other Ordinary Shares, including for all dividends and other distributions declared, made or paid on the Ordinary Shares, will be purchased on the same terms and conditions as the Ordinary Shares being issued or sold in the Global Offer and will form a single class for all purposes with the other Ordinary Shares.

Number of shares covered by Over-allotment Option:

23,922,236 Shares

Duration:

This option may be executed at any time during the Stabilisation Period.

 

 

 

Disclaimer

 

In connection with the offer of the above securities, the Stabilising Manager may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilising Manager will take any stabilisation action and any stabilisation action, if begun, may be ended at any time.

 

This announcement is for information only and does not constitute an offer or invitation to underwrite, subscribe for or otherwise acquire or dispose of any securities or investment advice in any jurisdiction in which such an offer or solicitation is unlawful, including without limitation, the United States, Australia, Canada, or Japan. Any failure to comply with these restrictions may constitute a violation of the securities laws of such jurisdictions.

 

This announcement and the information contained herein, is not an offer of securities for sale in, and is not for transmission to or publication, distribution or release, directly or indirectly, in the United States of America (including its territories and possessions, any state of the United States of America and the District of Columbia) (the "United States"). The securities being offered have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act"), or under any applicable securities laws of any state or other jurisdiction of the United States and may not be offered, sold, resold, transferred or delivered, directly or indirectly, in the United States unless registered under the Securities Act or pursuant to an exemption from, or in a transaction not subject to, such registration requirements and in accordance with any applicable securities laws of any state or other jurisdiction of the United States. No public offering of the securities discussed herein is being made in the United States.

 

This announcement is directed only at: (A) persons in member states of the European Economic Area (the "EEA") who are "qualified investors" within the meaning of Article 2(1)(e) of the EU Prospectus Directive (Directive 2003/71/EC (and amendments thereto, including Directive 2010/73/EU, to the extent implemented in the relevant member state of the EEA) and includes any relevant implementing measure in each relevant member state of the EEA) (the "Qualified Investors"); (B) in the United Kingdom, Qualified Investors who are persons who (i) have professional experience in matters relating to investments and who fall within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the "Order"); or (ii) are high net worth entities falling within Article 49 of the Order; or (iii) are persons to whom it may otherwise be lawfully communicated. If you are not a Relevant Person, you will not be eligible to participate in the offering, and you should not act upon, or rely on, this announcement.

 

END

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STAMABITMBATMLR
Date   Source Headline
7th Sep 20237:00 amRNSNotice of Capital Markets Day
6th Sep 20237:00 amRNSPublication of Circular, Notice of General Meeting
5th Sep 20237:00 amRNSAcquisition of Cascade Engineering Europe
23rd Aug 20237:00 amRNSDirector/PDMR Shareholding
22nd Aug 20237:00 amRNSDirector/PDMR Shareholding
21st Aug 20237:00 amRNSInterim dividend - Payment of dividend in Sterling
18th Aug 20239:00 amRNSDirector/PDMR Shareholding
10th Aug 20234:30 pmRNSInterim dividend
8th Aug 20237:00 amRNSHalf Year Results 2023
3rd Aug 20239:00 amRNSNotice of H1 2023 Trading Update
4th Jul 20231:08 pmRNSNotification of Transaction of PDMRs
30th May 20237:00 amRNSPayment of dividend in Sterling
26th May 20233:00 pmRNSHolding(s) in Company
16th May 202312:00 pmRNSResults of Annual General Meeting 2023
3rd May 20237:00 amRNSQ1 2023 Trading Update
20th Apr 20235:00 pmRNSNotification of Transaction of Executive Directors
19th Apr 20237:00 amRNSTech Showcase at e-Mobility Innovation Centre
17th Apr 20237:00 amRNSNotice of Q1 2023 Trading Update
11th Apr 20237:00 amRNSARA 2022, Sustainability Report 2022 & AGM 2023
6th Apr 20234:30 pmRNSCFO and Director Appointment
4th Apr 20237:00 amRNSDirector/PDMR Shareholding
21st Mar 20237:00 amRNSDirector/PDMR Shareholding
16th Mar 20237:00 amRNSResults for the year ended 31 December 2022
1st Mar 20233:00 pmRNSNotice of 2022 Full Year results presentation
31st Jan 20234:00 pmRNSHolding(s) in Company
18th Jan 20237:00 amRNSPost Close Trading Update
3rd Nov 20227:00 amRNSQ3 2022 Trading Update
2nd Nov 20222:00 pmRNSDirectorate Change
6th Sep 20227:00 amRNSDirectorate and Committee Change
22nd Aug 20227:00 amRNSInterim dividend - Payment of dividend in Sterling
10th Aug 20227:00 amRNSInterim Dividend
9th Aug 20227:00 amRNSHalf Year Results 2022
7th Jun 20227:00 amRNSDirectorate Change
1st Jun 20227:00 amRNSHolding(s) in Company
30th May 20227:00 amRNSFinal dividend for 2021
18th May 20225:30 pmRNSHolding(s) in Company
18th May 202211:00 amRNSResults of Annual General Meeting 2022
18th May 20227:00 amRNSHolding(s) in Company
17th May 20227:00 amRNSQ1 2022 Trading Update
11th Apr 20227:00 amRNSAnnual Report and Accounts 2021 and AGM 2022
6th Apr 20227:00 amRNSDirector/PDMR Shareholding
29th Mar 20227:00 amRNSDirector/PDMR Shareholding
25th Mar 20227:00 amRNSDirector/PDMR Shareholding
24th Mar 20227:00 amRNSDirector Declaration
15th Mar 20227:00 amRNSResults for the year ended 31 December 2021
8th Feb 20227:00 amRNSDirector/PDMR Shareholding
25th Jan 20227:01 amRNSRetirement of the Chair of the Board & Succession
25th Jan 20227:00 amRNSPost Close Trading Update
9th Dec 202112:16 pmRNSDirectorate Change
12th Nov 20213:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.